Geoffrey M. Parker's Net Worth
Estimate Recalculated Jun 10, 2025 03:17PM EST
Who is Geoffrey M. Parker
Geoffrey M. Parker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Anacor Pharmaceuticals Inc, ChemoCentryx, Inc., GENOPTIX INC, Tricida, Inc., PERRIGO Co plc, SUNESIS PHARMACEUTICALS INC, Better Therapeutics, Inc., and GENOMIC HEALTH INC.
SEC CIK
Geoffrey M. Parker's CIK is 0001491874
Past Insider Trading and Trends
2011 was Geoffrey M. Parker's most active year for acquiring shares with 16 total transactions. Geoffrey M. Parker's most active month to acquire stocks was the month of April. 2019 was Geoffrey M. Parker's most active year for disposing of shares, totalling 12 transactions. Geoffrey M. Parker's most active month to dispose stocks was the month of April. 2018 saw Geoffrey M. Parker paying a total of $1,600,883.30 for 122,186 shares, this is the most they've acquired in one year. In 2013 Geoffrey M. Parker cashed out on 80,000 shares for a total of $400,000.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
